Hugues Talbot

6PUBLICATIONS
54CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markersGeospatial information systems and geospatial data modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 04, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.

Barbara Pistilli, Fernanda Mosele, Noemie Corcos

|Nov 26, 2024
Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases.

Lama Dawi, Younes Belkouchi, Littisha Lawrance

|Jan 31, 2023
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy.

Younes Belkouchi, Hugues Talbot, Nathalie Lassau

|Aug 12, 2022
Toward semi-automatic biologically effective dose treatment plan optimisation for Gamma Knife radiosurgery.

Thomas Klinge, Hugues Talbot, Ian Paddick

|Mar 10, 2022
Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker.

Raphael Naccache, Younes Belkouchi, Littisha Lawrance

|May 09, 2019
Three-dimensional conditional random field for the dermal-epidermal junction segmentation.

Julie Robic, Benjamin Perret, Alex Nkengne

Pageof 1

Frequent Collaborators

3 joint publications

Littisha Lawrance

3 joint publications

Samy Ammari

2 joint publications

Younes Belkouchi

2 joint publications

Paul-Henry Cournede